For injectable routes, such as subcutaneous, research models might start with doses around 0.5mg to 2mg daily for an equivalent 70kg subject
Hormone therapy, including injections, can help balance hormones for pregnancy
This supply situation has driven interest in tirzepatide alternatives and in compounded formulations that may offer more reliable availability
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
